Job opportunity for M.Pharm, MSc, B.Pharm in Quality Assurance at Encube Ethicals

Encube is an integrated pharmaceutical company that specializes in the development and manufacturing of topical formulations such as creams, ointments, gels, lotions, and solutions. The company has a strong focus on contract development and manufacturing services.

Encube was founded by Shri Mehul Shah, who serves as the Promoter and Managing Director of the company. It was incorporated on September 7, 1995, and began its commercial operations on March 4, 1998. With over 24 years of experience in the industry, Encube has established itself as a reputable player in the field of topical formulations.

Job Title: Executive / Sr. Executive – Lab QA (Reviewer)

Qualification: MSc Chemistry / Microbiology B.Pharm/ M.Pharm

Experience: 6 to 7 Years

Job Description: As an Executive / Sr. Executive – Lab QA (Reviewer)

Responsibilities :

• Reviewing analytical data reports, instrument calibration reports, AMV, AMT, Stability Study Protocol/Reports generated by the Quality Control Department.
• Reviewing and investigating Out of Specification (OOS), Out of Trend (OOT), quality-relevant incidents, and non-conformance of the laboratory, and defining appropriate Corrective and Preventive Actions (CAPAs) in collaboration with the QC Department.
• Regularly observing and ensuring compliance with relevant activities.
• Possessing knowledge of High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and other instruments used in the QC department.
• Demonstrating a good understanding and knowledge of Caliber LIMS, QAMS, Empower, and Standalone system/data audit trails.

Note:

• The candidate must have a background in the pharmaceutical industry and relevant experience in Quality Control (QC).
• The candidate should be willing to work in all shifts.
• Please mention the subject of your email as “Application for the opening in Lab QA.”

To apply, please send your resume to santoshi.n@encubeethicals.com.

Application Deadline: 20th June 2023.